Schafer Boeder Selected Research

Schafer Boeder Research Topics

6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2024 - 01/2018
3	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 03/2024 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 02/2023 - 01/2021
2	COVID-19 01/2023 - 01/2021
2	Body Weight (Weight, Body) 01/2022 - 01/2019
2	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 01/2021
2	Infections 01/2021 - 01/2019
2	Hypertension (High Blood Pressure) 01/2021 - 08/2015
1	Critical Illness (Critically Ill) 01/2023
1	Sleepiness 08/2015

6	Insulin (Novolin)FDA Link 03/2024 - 01/2018
6	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 01/2019
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 01/2021
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 03/2024
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 03/2024
1	Insulin Lispro (Humalog)FDA Link 01/2022
1	CarbohydratesIBA 01/2022
1	Insulin Aspart (NovoLog)FDA Link 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Sodium-Glucose Transport ProteinsIBA 01/2021
1	SodiumIBA 01/2019
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019
1	SymportersIBA 01/2019
1	Glucagon Receptors (Glucagon Receptor)IBA 01/2018
1	volagidemabIBA 01/2018

2	Therapeutics 02/2023 - 01/2023
1	Injections 02/2023
1	Glycemic Control 01/2023
1	Off-Label Use 01/2021
1	Continuous Positive Airway Pressure 08/2015